Alessandro B.
- Country
- Italy
- Department
- Oncologia Medica - Ospedale di Sondrio
Research Overview
- Randomized Evaluation of Paclitaxel-Carboplatin with Maintenance Niraparib versus Paclitaxel-Carboplatin-Bevacizumab with Maintenance Niraparib-Bevacizumab in Advanced Ovarian Cancer
- Phase 3 Randomized Trial of Ensartinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer Patients with Prior Chemotherapy and No ALK TKI Treatment
- Evaluation of Diarrhea-Related Discontinuations in Early-Stage HER2+/HR+ Breast Cancer with Neratinib, Loperamide, and Colesevelam Prophylaxis
Data & Insights
Has run more than one trial at 15 of 138 partner sites.
Specializations
Lung Cancer Expertise
The investigator specializes in both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) treatments. Their research encompasses advanced therapeutic approaches for various lung cancer subtypes, including cases with EGFR mutations and ALK-positive NSCLC.
- Advanced and metastatic disease management
- Targeted therapy applications
- Post-surgical treatment strategies
Their work includes evaluation of innovative therapeutic agents in both early-stage and advanced disease settings.
Gastrointestinal Oncology
The investigator focuses on treating locally advanced rectal cancer and metastatic colorectal cancer, with particular attention to HER2-positive colorectal tumors. Their research includes investigating novel combination approaches incorporating chemotherapy and targeted therapies.
- Neoadjuvant treatment strategies
- Multi-modal therapy approaches
- Targeted therapeutic interventions
The research extends to innovative treatment combinations for improved patient outcomes.
Women's Cancers
The investigator conducts research in advanced ovarian cancer and HER2-positive breast cancer treatments. Their work encompasses both early-stage and advanced disease management, including studies of novel therapeutic combinations and maintenance strategies.
- Post-surgical treatment optimization
- Combined targeted therapy approaches
- Management of treatment-related effects
Their research includes evaluation of targeted therapies and maintenance treatments in gynecologic and breast cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.